COVID-19 Daily News: May 14

Early indicators: Investigational Convalescent Plasma is Safe for Patients with COVID-19

Mayo Clinic and collaborators today reported safety data on the first 5,000 hospitalized patients transfused with investigational convalescent plasma as part of the Food and Drug Administration’s national Expanded Access Program (EAP) for COVID-19. The early indicators suggest experimental convalescent plasma is safe in treating severely ill patients. At this time, convalescent plasma is the only antibody-based therapy available for COVID-19.

Read more.


Treating skin irritations from wearing face masks

"People are getting friction and irritation across their nasal bridge, behind their ears and perhaps under their chin," says Dr. Dawn Davis, a Mayo Clinic dermatologist. "That happens because of natural wear but also because the masks are tight, which is well-intentioned, but can strangulate the skin."

Read more.


Mayo Clinic Q&A Podcast: Surgical Practice During COVID-19

The COVID-19 pandemic forced elective surgeries to be delayed while hospitals prepared for the potential influx of COVID-19 patients. Thanks to effective efforts to flatten the curve and the lifting of executive stay-at-home orders, Mayo Clinic is again able to see patients for elective surgeries. What’s different for patients when having surgery during the coronavirus era? And what extra steps is Mayo Clinic taking to keep patients and staff safe? 

Read more.


Mayo Clinic Encourages Patients to Practice Safe Social Distancing Guidelines

Mayo Clinic has implemented enhanced cleaning, masking, testing and screening protocols for staff and patients. In addition, Mayo Clinic has implemented social distancing guidelines to help guide patients when they are on campus for appointments. 

Read more.

Samantha Rossi

Samantha Rossi

Samantha Rossi is a Marketing Associate at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.